Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

29%

2 of 7 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT01535911Not ApplicableActive Not Recruiting

Pilot Study of a Metabolic Nutritional Therapy for the Management of Primary Brain Tumors

Role: collaborator

NCT03436628Not ApplicableCompleted

Using an mHealth App to Transition Care of Type-1 Diabetes From Parents to Teens

Role: collaborator

NCT03906942Not ApplicableCompleted

Team Science to Promote Physical Activity

Role: collaborator

NCT02653170Not ApplicableCompleted

Michigan Stroke Transitions Trial

Role: collaborator

NCT02628379Completed

Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary

Role: collaborator

NCT02337296Not ApplicableCompleted

An Intervention to Promote Oral Agent Adherence and Symptom Management: ADHERE

Role: collaborator

NCT01889511Not ApplicableCompleted

Text Messaging to Improve Adherence to Oral Chemotherapy Agents

Role: collaborator

NCT01561469Completed

Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin

Role: collaborator

All 8 trials loaded